Clinical Trial

Propel Drug-Eluting Sinus Implant Family IBUKI Cohort

Recruiting
View on ClinicalTrials.gov →
Summary
To confirm clinical safety and performance for the PROPEL family of products when used according to IFUs and standard of care in Japan.
Trial Details
NCT Number NCT07546682
Lead Sponsor Medtronic
Conditions Chronic Rhinosinusitis (CRS)
Enrollment 100 participants
Start Date 2026-04
Primary Completion 2027-05 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-04-23